Send us a link

Subscribe to our newsletter

How to Navigate the Challenges of Corporate-academia Research Partnerships

How to Navigate the Challenges of Corporate-academia Research Partnerships

Many research projects draw on sources of funding from the corporate world. Fola Adeleke discusses the challenges inherent to this kind of research and outlines three key considerations for researchers engaging with corporate partners.  

'Industry Scientists Are Often Misunderstood: Here’s Why I Chose This Path'

'Industry Scientists Are Often Misunderstood: Here’s Why I Chose This Path'

"I don’t think industry would be a good fit for me,” the student said, “I’m not money-motivated.” As an industry scientist myself, I struggled to hide my surprise.

How an Early Oil Industry Study Became Key in Climate Lawsuits

How an Early Oil Industry Study Became Key in Climate Lawsuits

For decades, 1960s research for the American Petroleum Institute warning of the risks of burning fossil fuels had been forgotten. But two papers discovered in libraries are now playing a key role in lawsuits aimed at holding oil companies accountable for climate change.

In Unpublished Paper, Former White House Climate Adviser Calls Methane 'irrelevant' to Climate

In Unpublished Paper, Former White House Climate Adviser Calls Methane 'irrelevant' to Climate

Research in the US aims to support rollback of methane rules.

Associations Between Industry Involvement and Study Characteristics at the Time of Trial Registration in Biomedical Research

Associations Between Industry Involvement and Study Characteristics at the Time of Trial Registration in Biomedical Research

Study investigates whether industry involvement in biomedical research affects trial design. A reduced use of active controls (such as alternate treatment or standard care) was found in trials with industry involvement, which can have the side effect of making results look more favourable than they actually are.

An HIV Treatment Cost Taxpayers Millions. The Government Patented It. But a Pharma Giant Is Making Billions.

An HIV Treatment Cost Taxpayers Millions. The Government Patented It. But a Pharma Giant Is Making Billions.

The extraordinary standoff between the CDC and a drug company over patent rights raises a big question for the Trump administration: How aggressively should the government attempt to enforce its patents against an industry partner?